Treatment options and tracking of COVID-19 have dramatically improved, but the pandemic keeps shifting, and public fatigue is fraying Minnesota s response.
Doctors who treat COVID-19 patients in the Twin Cities are voicing optimism over Pfizer's antiviral pill, known as Paxlovid. Pfizer released new data from its clinical trials of Paxlovid Tuesday, showing the pill significantly reduced the risk of hospitalization and death.
Doctors who treat COVID-19 patients in the Twin Cities are voicing optimism over Pfizer's antiviral pill, known as Paxlovid. Pfizer released new data from its clinical trials of Paxlovid Tuesday, showing the pill significantly reduced the risk of hospitalization and death.